Maragos WF - Search Results

1

Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function.

Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA. Maragos WF, et al. J Neurochem. 2002 Nov;83(4):955-63. doi: 10.1046/j.1471-4159.2002.01212.x. J Neurochem. 2002. PMID: 12421368 Free article.

2

Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction.

Theodore S, Cass WA, Nath A, Steiner J, Young K, Maragos WF. Theodore S, et al. Among authors: maragos wf. Neurobiol Dis. 2006 Sep;23(3):663-8. doi: 10.1016/j.nbd.2006.05.005. Epub 2006 Jul 7. Neurobiol Dis. 2006. PMID: 16828290

3

Human immunodeficiency virus-1 protein tat and methamphetamine interactions.

Theodore S, Stolberg S, Cass WA, Maragos WF. Theodore S, et al. Among authors: maragos wf. Ann N Y Acad Sci. 2006 Aug;1074:178-90. doi: 10.1196/annals.1369.018. Ann N Y Acad Sci. 2006. PMID: 17105916

4

HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.

Cass WA, Harned ME, Peters LE, Nath A, Maragos WF. Cass WA, et al. Among authors: maragos wf. Brain Res. 2003 Sep 12;984(1-2):133-42. doi: 10.1016/s0006-8993(03)03122-6. Brain Res. 2003. PMID: 12932847

5

Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum.

Theodore S, Cass WA, Maragos WF. Theodore S, et al. Among authors: maragos wf. Exp Neurol. 2006 Jun;199(2):490-8. doi: 10.1016/j.expneurol.2006.01.009. Epub 2006 Feb 28. Exp Neurol. 2006. PMID: 16510141

6

Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.

Theodore S, Cass WA, Maragos WF. Theodore S, et al. Among authors: maragos wf. Neuroscience. 2006 Feb;137(3):925-35. doi: 10.1016/j.neuroscience.2005.10.056. Epub 2005 Dec 7. Neuroscience. 2006. PMID: 16338084

7

Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice.

Maragos WF, Young KL, Altman CS, Pocernich CB, Drake J, Butterfield DA, Seif I, Holschneider DP, Chen K, Shih JC. Maragos WF, et al. Neurochem Res. 2004 Apr;29(4):741-6. doi: 10.1023/b:nere.0000018845.82808.45. Neurochem Res. 2004. PMID: 15098936

8

Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.

Theodore S, Cass WA, Nath A, Maragos WF. Theodore S, et al. Among authors: maragos wf. Curr HIV Res. 2007 May;5(3):301-13. doi: 10.2174/157016207780636515. Curr HIV Res. 2007. PMID: 17504172 Review.

9

HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum.

Theodore S, Cass WA, Dwoskin LP, Maragos WF. Theodore S, et al. Among authors: maragos wf. Synapse. 2012 Aug;66(8):755-7. doi: 10.1002/syn.21564. Epub 2012 May 23. Synapse. 2012. PMID: 22517264 Free PMC article. No abstract available.

10

Pre- or post-treatment with the mitochondrial uncoupler 2,4-dinitrophenol attenuates striatal quinolinate lesions.

Maragos WF, Rockich KT, Dean JJ, Young KL. Maragos WF, et al. Brain Res. 2003 Mar 21;966(2):312-6. doi: 10.1016/s0006-8993(02)04225-7. Brain Res. 2003. PMID: 12618355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters